Sartorius Stedim Biotech Acquires Cellca
According to Sartorius Stedim Biotech, this acquisition expands its service offering for process development.
Sartorius Stedim Biotech, an international supplier for the pharma and biotech industries, announced that it has acquired Cellca GmbH based in Laupheim, Germany.
Cellca was founded in 2005 and has approximately 30 employees. The company’s major customers are from the biopharmaceutical industry, including biosimilar firms that do not or only partly conduct their process development in their in-house facilities. Cellca generated sales revenue of approximately EUR6 million in 2014.
According to Sartorius Stedim Biotech, this acquisition expands its service offering for process development in addition to its two recent acquisitions of BioOutsource and TAP Biosystems.
Source: Sartorius
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
